Skip to main content
. 2022 Jun 1;41(9):2745–2754. doi: 10.1007/s10067-022-06164-5

Table 3.

Body compositions at baseline and 12 months for the patients with PsA and the controls

PsA group Within-group difference
p-value
Control group Within-group difference
p-value
Between-group difference
p-value

BL

(n = 41)

M12

(n = 39)

BL-M12

BL

(n = 42)

M12

(n = 39)

BL-M12 BL M12
Body weight, kg

106.3

(95.8; 113.6)

87.5

(80.6; 95.5)

 < 0.001

107.0

(97.0; 122.2)

87.6

(78.2; 97.5)

 < 0.001 0.313 0.730
BMI, kg/m2

35.2

(34.1; 38.1)

30.5

(28.0; 32.9)

 < 0.001

38.5

(36.9; 41.7)

32.6

(30.3; 34.8)

 < 0.001  < 0.001 0.021
WC, cm

116.0

(112.0; 122.0)

97.5

(90.0; 105.0)

 < 0.001

117.0

(107.0; 126.5)

100.0

(92.0; 109.0)

 < 0.001 0.680 0.572
Tot fat mass, kg

48.5

(41.7; 56.7)

33.9

(25.9; 40.5)

 < 0.001

50.7

(46.2; 59.2)

36.8

(27.8; 39.5)

 < 0.001 0.041 0.880
Tot lean mass, kg

51.9

(45.9; 61.8)

48.3

(43.6; 58.3)

 < 0.001

49.7

(46.9; 58.6)

45.6

(44.5; 57.9)

 < 0.001 0.905 0.880
Lean mass arm, kg

2.8

(2.5; 3.9)

2.5

(2.1; 3.4)

 < 0.001

2.6

(2.4; 3.3)

2.6

(2.2; 3.4)

 < 0.001 0.542 0.651
Lean mass leg, kg

8.9

(8.0; 10.9)

8.4

(7.2; 9.8)

 < 0.001

9.1

(8.5; 10.4)

8.1

(7.7; 9.8)

 < 0.001 0.489 0.930

For continuous variables, median (IQR) per participant is presented. BMI, body mass index; WC, waist circumference. Missing values at 12 months: control group DXA (n = 19)